期刊文献+

肿瘤坏死因子介导缺氧性肺动脉高压的实验研究 被引量:5

Experimental study of hypoxic pulmonary hypertention induced by TNF-αin rats
下载PDF
导出
摘要 目的研究TNF-α在缺氧性肺动脉高压中的作用。方法将32只SD大鼠分为:①正常组8只,不缺氧处理;②单纯缺氧组,每只于缺氧前腹腔注射生理盐水lml,每天缺氧8小时,共2周;③缺氧2周+TNF-α组:每天缺氧前腹腔注射TNF-α(0.26mg/kg);④缺氧2周+TNF-α+L-Arg组:每天缺氧前腹腔注射TNF-α(0.26mg/kg)和L-Arg(100mg/kg)。缺氧完成后测各组大鼠血流动力学改变,并作肺病理切片、肺血管图像分析。结果单纯缺氧组和加入TNF-α组其肺动脉压明显高于正常组和加入TNF-α+L-Arg组(2.98±0.34kPa和3.68±0.45kPaVS2.05±0.13kPa和2.35±0.19kPa),且各组间均有显著差异(P<0.05),单纯缺氧组和加入TNF-α组其肺小血管壁厚度和管壁面积均明显增加,显著高于正常组和加入TNF-α+L-Arg组,差异有显著性意义(P<0.05),单纯缺氧组和加入TNF-α组之间差异无显著性意义。结论TNF-α能增强慢性缺氧性肺动脉高压,L-Arg能拮抗其作用。 Objective To study the effects of TNF-αon the chronic hypoxic pulmonary hypertention in rats.Methods The animal model of chronic hypoxic pulmonary hypertention in rats were builted.At the same time,bolus injection of TNF-α(0.26mg/kg)and L-Arg(100mg/kg) were given in rats,then the hymodynamic and pathologic changes were observed.Results The mPAP which injected TNF-αgroup was significantly hight than the control group and hypoxic two weeks group(3.68±0.45kPa VS 2.05±0.13kPa and 2.98±0.34kPa,P<0.05). Comination injection TNF-αand L-Arg could decrease mPAP(2.35±0.19kPa).Hypoxic and TNF-αcould increase the pulmonary arteries's medial thickness and medial area.Conclusion TNF-αcan increase the hypoxic pulmonary hypertention and thicken the pulmonary arteries. L-Arg can antagonite the effects of TNF-α.
出处 《中国现代医药杂志》 2004年第5期24-26,共3页 Modern Medicine Journal of China
关键词 肿瘤坏死因子 缺氧性肺动脉高压 药理实验 L-精氨酸 TNF-αHypoxic pulmonary hypertention
  • 相关文献

参考文献7

  • 1薛全福,谢剑鸣.常压缺氧性大鼠肺动脉高压模型的建立[J].中华结核和呼吸杂志,1989,12(6):350-352. 被引量:157
  • 2孙波 刘文利.右心导管测定大鼠肺动脉压的实验方法[J].中国医学科学院学报,1984,6:465-465.
  • 3王荣丽,王曾礼,孔古娅.TNF-α对大鼠血流动力学的影响及与NO关系的研究[J].四川医学,1998,19(1):44-45. 被引量:9
  • 4[4]Stevens TP,Janssend A, Tucker B, et a1. Acute and long term TNF-α administration increase pulmonary vascular reactivity in isolated Rat lungs.J Appl physiol, 1992, 73: 708
  • 5[5]Takabatake N, Nakamura H,Abe S, et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-α system in patients with chronic obstructive pulmonary disease. Am J Respir Crit care med, 2000 Apr, 16(4pt l):1179-84
  • 6[6]Uttanc G, Hssid A. Nitric oxide- generating vasodilators and &- Bromo cyclic quanosine monophosphate inhibits mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J clin lnvest, 1989,83:1774
  • 7[7]Smith RI,Iccarthy J. Sack IN:TNF-α is required for hypoxa- mediated right ventricular hypertrophy.mol cell Biochem, 2001 219L1-2:139-143

共引文献248

同被引文献39

  • 1张蔷,林勇.CTGF在低氧性肺血管重建中的作用[J].东南大学学报(医学版),2005,24(6):395-398. 被引量:5
  • 2孙菊光,奚肇庆,姜静,朱萱萱,洪建军,蒋萌,邹建东,徐艳,甘咏梅.复方薤白胶囊对野百合碱诱导肺动脉高压大鼠ET、TNFα含量的影响[J].东南大学学报(医学版),2006,25(5):337-340. 被引量:17
  • 3李志超,张福琴,赵德化,孙本韬,梅其炳,林树新.内皮素和一氧化氮在野百合碱引起肺动脉高压时的变化[J].第四军医大学学报,1996,17(6):412-414. 被引量:5
  • 4孙波 孙文利.右心导管测定大鼠肺动脉高压的实验方法[J].中国医学科学院学报,1984,6(6):465-465.
  • 5Lee J H, Lee D S, Kim E K, et al. Sirnvastatin inhibits cigarette smoking-induced empsema and pulmonary hypertension in rat lungs[J ]. Am J Respir Crit Care Med, 2005, 172 (8) :987-993.
  • 6Cowan K N, Heilbut A, Hum PIT , et al. Complete reversal of falal pulmonmary pertenslon in rals by a serine elastase inhibitor[J ]. Nat Med, 2000,6 (6) : 698-702.
  • 7Stenmark K R, McMurtry I F. Vascular remodeling versus vasoconstriction in chronic hypoxlc pulmonary hypertension :A time for reappraisal? [J]. Circ Res,2005,97(2) :95-98.
  • 8Campian M E, Hardziyenka M, Michel M C, et al. How valid are animal models to evaluated treatment for pulmonary hypertension [ J ]. Naunyn-Sehnliedeberg' s Aich Pharmacol, 2006, 373(3): 391-400.
  • 9Kwak B, Mulhaupt F, Myit S, et al. Statins as a newly recognized type of immunomodulator [ J ]. Nat Med, 2000, 6 (12) : 1399-1402.
  • 10Antonescu-Turcu A L, Tomic R. C-reactive protein and copeptin: prognostic predictors in chronic obstructive pul- monary disease exacerbations [ J ]. Curr Opin Pulm Med, 2009, 15(2): 120-125.

引证文献5

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部